Scientific programme

3rd NordiQC Conference on Applied Immunohistochemistry 6th-9th June 2017
Red text is hyperlinked

Print: NordiQC_programme_2017 (pdf)
Print: Conference poster (pdf)

Tuesday 6th June 2017

14:00 – 18:00 Registration
16:00 – 18:00 Industrial Symposium – Meet the Exhibitors
18:00 – 20:00 Informal get-together buffet

Wednesday 7th June 2017

08:00 – 09:00 Registration
09:00 – 09:15 Mogens Vyberg, DK: Welcome
09:15 – 10:15
Keynote lecture
Clive Taylor, CA: IHC in the era of precision medicine
10:15 – 10:45 Coffee. Exhibitions and posters
10:45 – 12:15
& Cancer
Manuel Salto-Tellez, UK: Digital Pathology workflows for Personalised Medicine and Cancer Immunology (40+5)
Torben Steiniche, DK: Quantification of inflammatory cells in tumour microenvironment (40+5)
12:15 – 13:30 Lunch. Exhibitions and posters
13:30 – 15:20
PD-L1 in
Allen Gown, Wash.: IHC to determine PD-L1 expression in non-small cell lung and other tumors as a predictor of patient response to drugs targeting immune checkpoints: The rationale, predictive value, confusion and potential of companion diagnostics (40+5)
Henrik Hager, DK: PD-L1 testing as an integrated part of comprehensive lung pathology (35+5)
Andreas Scheel, DE: German PD-L1 ring trials (20+5)
15:20 – 15:45 Coffee. Exhibitions and posters
15:45 – 17:00
PD-L1 in
Emina Torlakovic, ON: cIQc Non-Small Cell Lung Cancer EQA for PD-L1 (20+5)
Suzanne Parry, UK: NEQAS ICC & ISH: Non-Small Cell Lung Cancer EQA for PD-L1 (20+5)
Søren Nielsen, DK: NordiQC Non-Small Cell Lung Cancer EQA for PD-L1 (20+5)
17:30 – 19:30 Reception at KUNSTEN Museum of Modern Art

Thursday 8th June 2017

09.00 – 10:40
Evolution in



Carol Cheung, ON: Fit-for-purpose Approach to Classification of Clinical Immunohistochemistry Tests (Evolution series I) (20+5)
Emina Torlakovic, ON: Immunohistochemistry Test Performance Characteristics (Evolution series II) (20+5)
Emina Torlakovic, ON: Technical Validation of IHC Assays in Clinical IHC Laboratories (Evolution series III) (25+5)
Carol Cheung, ON: Tissue Tools for Quality Assurance in IHC (Evolution series IV) (15+5)
10:40 – 11:10 Coffee. Exhibitions and posters
11:10 – 12:30
Breast cancer
Johan Hartman, SE: Proliferation associated biomarkers in breast pathology (35+5)
Tibor Tot, SE: Gene-protein assay for assessing HER2 status in breast carcinoma (35+5)
12:30 – 13:30 Lunch. Exhibitions and posters
13:30 – 15:20
Breast cancer 


Viktoria Gaspar, SE: Molecular subtyping in breast carcinoma, Swedish experiences (20+5)
Anne-Vibeke Lænkholm, DK: Molecular subtyping in breast carcinoma, Danish experiences (20+5)
Andrew Dodson, UK: Standardisation of Ki67 in breast cancer prognostication (30+5)
Rasmus Røge, DK: Digital image analysis for Ki67 in breast cancer (20+5)
15:20 – 15:50 Coffee. Exhibitions and posters
15:30 – 17:35
GI tract cancer 
Ari Ristimäki, FI: Colorectal cancer – update on immunohistochemistry and molecular morphology (30+5)
Sofie Lunden Nielsen, DK: Digital image analysis of HER2 status in gastric and gastroesophageal cancer (15+5)
Tine Plato-Hansen, DK: Tumour budding in colorectal adenocarcinoma (20+5)
Mogens Vyberg, DK: EQA of GI cancer markers (20+5)
18:45 – Hotel Comwell Hvide Hus: Conference dinner

 Friday 9th June 2017

09:00 – 10:30
Stewart Fleming, UK: Tumours of kidney and urinary tract – update on WHO classification, IHC and molecular morphology (30+5)
Glen Kristiansen, DE: Tumours of the prostate and testis – update on WHO classification, IHC and molecular morphology (30+5)
Jan Klos, NO: EQA of IHC for urogenital tumour markers (20+5)
10:30 – 11:00 Coffee. Exhibitions and posters
11:00 – 12:25
Soft tissue
Cyril Fisher, UK: Tumours of soft tissues – update on IHC and molecular morphology (50+10)
Mogens Vyberg, DK: EQA of mesenchymal markers (20+5)
12:25 – 13:00
Søren Nielsen, DK: NordiQC – seminal results during 15 years (20+5)
Mogens Vyberg, DK: Closing the conference
13:00 Lunch – restaurant and to-go